The gain of function (GOF) TP53 mutation results in a new function or altered expression; in GBM, it leads to increased malignancy of cells by increasing their proliferation, migration, invasion, metastasis, drug resistance, and genome instability, and increasing survival [55,56,57,58]. The gene discussed is TP53; the disease is glioblastoma.